Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
基本信息
- 批准号:7350248
- 负责人:
- 金额:$ 26.55万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2006
- 资助国家:美国
- 起止时间:2006-02-01 至 2010-01-31
- 项目状态:已结题
- 来源:
- 关键词:AffinityApoptosis InhibitorBindingBiochemical GeneticsBiological ModelsBoxingCDC6 geneCardiovascular systemCellsChromosomal InstabilityClassCoupledDefectDissectionEmbryoEmbryonic HeartFamilyFemale infertilityFigs - dietaryGoalsGrowthHIV-1Half-LifeHeart HypertrophyHormonesIn VitroIntegraseKnockout MiceMammalsMediatingModelingMonitorMusMuscle ProteinsMyocardialN DomainN-terminalNamesNeural Tube DevelopmentNeurotransmittersOryctolagus cuniculusPTPRJ genePathway interactionsPhenotypePhysiologicalPhysiological ProcessesPolymeraseProcessProductionProteinsProteolysisProteomicsRGS ProteinsRNA InterferenceReportingReticulocytesRetroviridaeRoleSaccharomyces cerevisiaeSignal PathwaySignal TransductionSindbis VirusSpecificitySubstrate InteractionSystemTechniquesTechnologyTestingUbiquitinZinc Fingersbasecohesinhuman CDC6 proteinin vivoinhibitor/antagonistlipid metabolismmalemammalian genomemutantnovelprotein degradationrecogninssmall moleculesynthetic peptideubiquitin ligaseubiquitin-protein ligase
项目摘要
The ubiquitin-dependent N-end rule pathway relates the in vivo half-life of a protein to the identity of its N-terminal
residue. We have previously reported UBR1 and UBR2 as its functionally overlapping E3s and elucidated their in
vivo roles using mouse knockout approach. Unexpectedly, although both UBR1 and UBR2 strongly bound to
N-degrons, UBR1'^'UBR2^' cells still retained the N-end rule E3 activities, indicating the presence of yet
unidentified N-recognins (N-degron-Recognizing E3s). The goal of this study is to identify and characterize
N-recognins and their substrates and to elucidate the physiological meaning of their E3-substrate interaction. To
identify mammalianN-recognins, we developed a novel affinity-based proteomic approach using synthetic peptides
bearing N-degron, yielding a novel 570 kDa-protein named UBR4 and a 300 kDa-E3 ligase EDO (termed UBR5).
UBR1, -2, -4, and -5 shared a zinc finger-like domain named the UBR box. Mammalian genome appearsto encode
seven UBR proteins, named UBR1 through UBR7. Further, by using a functional proteomic approach, we have
obtained -35 candidate N-end rule substrates from -14,000 different proteins expressed in the rabbit reticulocyte
lysates. Preliminary characterization of candidate substrates unveiled several novel in vivo N-end rule substrates
(RGS4, RGS5, RGS16, and CDC6), the first to be identified in mammals. To further extend our current
understanding of the N-end rule pathway, we propose the following Aims. Aim 1. To characterize UBR box
proteins as candidate N-recoqnins. We will examine: 1) proteolysis of model N-end rule substrates in UBR mutant
cells, 2) the interaction and specificity of UBR box proteins with N-degrons, and 3) in vitro ubiquitylation of model
substrates by UBR box proteins. Aim 2. To determine whether UBR box motif is the recognition domain for
N-degron. We will determine whether the UBR boxes of N-recognins are required and sufficient for direct binding
to N-degrons and identify essential residues for recognition of N-degron. Aim 3. To identify physiological N-end
rule substrates. We will dissect proteolysis of candidate substrates in reticulocyte lysates and UBR mutant cells,
determine the N-recognin-substrate interaction, and test whether N-recognins support substrate ubiquitylation in
vitro. Aim 4. To dissect physiological processes underlying identified N-end rule substrates. We will examine the
physiological significance underlying the N-end rule dependent proteolysis of RGS4, -5, and -16, emerging in vivo
N-end rule substrates.
泛素依赖的n端规则途径将蛋白质的体内半衰期与其n端身份联系起来
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
YONG TAE KWON其他文献
YONG TAE KWON的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('YONG TAE KWON', 18)}}的其他基金
Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
- 批准号:
7577417 - 财政年份:2006
- 资助金额:
$ 26.55万 - 项目类别:
Proteomics of Ubiquitin-Dependent N-End Rule Pathway
泛素依赖性 N 端规则途径的蛋白质组学
- 批准号:
7037956 - 财政年份:2006
- 资助金额:
$ 26.55万 - 项目类别:
相似海外基金
Parameter-kinetics of apoptosis inhibitor of macrophage (AIM) in contrast-induced nephropathy
对比剂肾病中巨噬细胞凋亡抑制剂(AIM)的参数动力学
- 批准号:
21K15853 - 财政年份:2021
- 资助金额:
$ 26.55万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Epidemiological study of association between serum level of apoptosis inhibitor of macrophage (AIM) and incidence of metabolic syndrome or abnormal glucose metabolism
血清巨噬细胞凋亡抑制剂(AIM)水平与代谢综合征或糖代谢异常发生率相关性的流行病学研究
- 批准号:
15K19229 - 财政年份:2015
- 资助金额:
$ 26.55万 - 项目类别:
Grant-in-Aid for Young Scientists (B)
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
9272805 - 财政年份:2015
- 资助金额:
$ 26.55万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
8990167 - 财政年份:2015
- 资助金额:
$ 26.55万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence.
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持久性方面的作用。
- 批准号:
9089882 - 财政年份:2015
- 资助金额:
$ 26.55万 - 项目类别:
Evaluating the role of the novel apoptosis inhibitor TRAILshort, in maintaining HIV persistence
评估新型细胞凋亡抑制剂 TRAILshort 在维持 HIV 持续存在方面的作用
- 批准号:
10427482 - 财政年份:2015
- 资助金额:
$ 26.55万 - 项目类别:
Role of apoptosis inhibitor of macrophage (AIM) in the pathogenesis of intractable lung diseases
巨噬细胞凋亡抑制剂(AIM)在难治性肺部疾病发病机制中的作用
- 批准号:
25670398 - 财政年份:2013
- 资助金额:
$ 26.55万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Rescue of potential oocytes in livestock ovaries by artificial control of apoptosis inhibitor
通过人工控制凋亡抑制剂拯救家畜卵巢中的潜在卵母细胞
- 批准号:
24658231 - 财政年份:2012
- 资助金额:
$ 26.55万 - 项目类别:
Grant-in-Aid for Challenging Exploratory Research
Relationship of human apoptosis inhibitor NAIP1 between natural resistance against Legionellainfection
人凋亡抑制剂NAIP1与军团菌感染自然抵抗力的关系
- 批准号:
22591108 - 财政年份:2010
- 资助金额:
$ 26.55万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Non-canonical functions of the apoptosis inhibitor Bcl-xL
凋亡抑制剂 Bcl-xL 的非典型功能
- 批准号:
8205434 - 财政年份:2010
- 资助金额:
$ 26.55万 - 项目类别:














{{item.name}}会员




